
Eplus3D IPO withdrawal leads to regulatory warnings for CITIC Securities sponsors
Hardware
Originally reported by lanjinger.com
Eplus3D (Hangzhou Eplus3D Technology Co., Ltd.), a Chinese industrial metal AM OEM and national-level specialized "Little Giant" enterprise, withdrew its Shanghai Stock Exchange STAR Market IPO application in March 2026, originally filed June 2025 with a planned raise of 1.205 billion RMB. Months after the withdrawal, the Shanghai Stock Exchange issued regulatory warning letters to the company, three senior executives (Chairman Li Jianhao, General Manager Wu Pengyue, and CFO Li Yong), and two CITIC Securities sponsors (Dong Chao and Yu Qidong) for failures in due diligence and disclosure. The exchange's on-site inspection found that Eplus3D had systematically backfilled R&D time sheets, waste disposal records, and project documentation after the fact, with contradictory data across internal systems, and that the sponsors failed to verify R&D expense accuracy or investigate suspicious financial and personnel ties between a minor shareholder (Hangzhou Lansheng) and the controlling shareholder (Yongsheng Holding Group).
This event fits the recurring pattern of Chinese capital market discipline tightening around IPO governance, particularly for technology companies with opaque R&D accounting. For the AM industry, the case underscores that Chinese metal AM OEMs-which have rapidly scaled production and gained export traction in consumer electronics and aerospace-face increasing scrutiny on internal controls as they seek public listings. The withdrawal and subsequent regulatory action highlight a gap between the sector's manufacturing capability and its financial governance maturity, a concern for investors evaluating Chinese AM companies. The case also updates the debate on whether rapid growth in Chinese AM has been accompanied by adequate corporate infrastructure, especially in R&D capitalization and related-party transaction disclosure.
From an expert standpoint, this is a procedural enforcement action, not a judgment on Eplus3D's technology or market position. The practical implication is that Chinese AM companies pursuing IPOs must now invest in rigorous R&D documentation and internal audit systems comparable to Western standards, or face post-withdrawal liability. For buyers and partners evaluating Eplus3D's machines-which compete with BLT and Farsoon in LPBF-the technology remains credible, but the governance gap introduces counterparty risk that should be factored into qualification and supply agreements.
Topics